Trafalgar International (GCAN) Non-Current Debt (2020 - 2023)
Greater Cannabis Company (GCAN) posted quarterly Non-Current Debt of $36000.0 for Q3 2023, down 73.33% year-over-year from $135000.0 in Q3 2022, and down 73.33% quarter-over-quarter from $135000.0 in Q3 2022.
Trafalgar International (GCAN) Non-Current Debt (2020 - 2023) Analysis & Trends
Greater Cannabis Company's Non-Current Debt history runs 4 years deep, the most recent figure standing at $36000.0 for Q3 2023.
- In Q3 2023, Non-Current Debt fell 73.33% year-over-year to $36000.0; the TTM figure through Sep 2023 stood at $36000.0 (down 73.33% YoY), while the FY2020 annual figure was $325212.0, changed N/A from the prior year.
- Non-Current Debt for Q3 2023 stood at $36000.0, down from $135000.0 in the prior quarter.
- The five-year high for Non-Current Debt was $325212.0 in Q4 2020, with the low at $22500.0 in Q1 2021.
- The 4-year median for Non-Current Debt is $101041.0 (2020), against an average of $142074.4.
- The sharpest annual moves came in 2021 and 2022: Non-Current Debt slumped 86.39% in 2021, then climbed 11.11% in 2022.
- Greater Cannabis Company's Non-Current Debt stood at $325212.0 in 2020, then slipped by 4.35% to $311050.0 in 2021, then plunged by 56.6% to $135000.0 in 2022, then plunged by 73.33% to $36000.0 in 2023.
- Business Quant data shows GCAN's Non-Current Debt at $36000.0 in Q3 2023, $135000.0 in Q3 2022, and $25000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 130.00 Mn |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 36,000.00 |
| Sep 30, 2022 | 135,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Sep 30, 2021 | 311,050.00 |
| Jun 30, 2021 | 22,500.00 |
| Mar 31, 2021 | 22,500.00 |
| Dec 31, 2020 | 325,212.00 |
| Sep 30, 2020 | 311,050.00 |
| Jun 30, 2020 | 67,082.00 |
| Mar 31, 2020 | 165,350.00 |